307 related articles for article (PubMed ID: 31342543)
1. Optimizing Vancomycin Use Through 2-Point AUC-Based Therapeutic Drug Monitoring in Pediatric Patients.
Suchartlikitwong P; Anugulruengkitt S; Wacharachaisurapol N; Jantarabenjakul W; Sophonphan J; Theerawit T; Chatsuwan T; Wattanavijitkul T; Puthanakit T
J Clin Pharmacol; 2019 Dec; 59(12):1597-1605. PubMed ID: 31342543
[TBL] [Abstract][Full Text] [Related]
2. Correlation of the vancomycin 24-h area under the concentration-time curve (AUC
Issaranggoon Na Ayuthaya S; Katip W; Oberdorfer P; Lucksiri A
Int J Infect Dis; 2020 Mar; 92():151-159. PubMed ID: 31935538
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of clinical outcome in children and adolescents receiving vancomycin for invasive infections due to methicillin-resistant Staphylococcus aureus: impact of increasing vancomycin MICs.
Arun A; Swamy S; Jacob K; Sharma R; Kohlhoff SA; Hammerschlag MR
Minerva Pediatr; 2018 Jun; 70(3):207-211. PubMed ID: 28006894
[TBL] [Abstract][Full Text] [Related]
4. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD
Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357
[TBL] [Abstract][Full Text] [Related]
5. Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.
Fukumori S; Tsuji Y; Mizoguchi A; Kasai H; Ishibashi T; Iwamura N; To H
J Clin Pharm Ther; 2016 Aug; 41(4):399-402. PubMed ID: 27144370
[TBL] [Abstract][Full Text] [Related]
6. The dosing and monitoring of vancomycin: what is the best way forward?
Drennan PG; Begg EJ; Gardiner SJ; Kirkpatrick CMJ; Chambers ST
Int J Antimicrob Agents; 2019 Apr; 53(4):401-407. PubMed ID: 30599240
[TBL] [Abstract][Full Text] [Related]
7. Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.
Song KH; Kim HB; Kim HS; Lee MJ; Jung Y; Kim G; Hwang JH; Kim NH; Kim M; Kim CJ; Choe PG; Chung JY; Park WB; Kim ES; Park KU; Kim NJ; Kim EC; Oh MD
Int J Antimicrob Agents; 2015 Dec; 46(6):689-95. PubMed ID: 26555059
[TBL] [Abstract][Full Text] [Related]
8. Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.
Jung Y; Song KH; Cho Je; Kim HS; Kim NH; Kim TS; Choe PG; Chung JY; Park WB; Bang JH; Kim ES; Park KU; Park SW; Kim HB; Kim NJ; Oh MD
Int J Antimicrob Agents; 2014 Feb; 43(2):179-83. PubMed ID: 24315788
[TBL] [Abstract][Full Text] [Related]
9. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate.
Frymoyer A; Hersh AL; Benet LZ; Guglielmo BJ
Pediatr Infect Dis J; 2009 May; 28(5):398-402. PubMed ID: 19295465
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the mathematical equation and trapezoidal approach for 24 h area under the plasma concentration-time curve calculation in patients who received intravenous vancomycin in an acute care setting.
Chanapiwat P; Paiboonvong T; Rattanaumpawan P; Montakantikul P
Pharmacol Res Perspect; 2023 Feb; 11(1):e01046. PubMed ID: 36588162
[TBL] [Abstract][Full Text] [Related]
11. AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug.
Brown DL; Lalla CD; Masselink AJ
Ther Drug Monit; 2013 Aug; 35(4):443-9. PubMed ID: 23851909
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin area under the curves estimated with pharmacokinetic equations using trough-only data.
Fewel N
J Clin Pharm Ther; 2021 Oct; 46(5):1426-1432. PubMed ID: 34169543
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.
Moise-Broder PA; Forrest A; Birmingham MC; Schentag JJ
Clin Pharmacokinet; 2004; 43(13):925-42. PubMed ID: 15509186
[TBL] [Abstract][Full Text] [Related]
14. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
Ploessl C; White C; Manasco K
Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin AUC24 /MIC Ratio in Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia.
Ji M; Kim HK; Kim SK; Lee W; Sung H; Chun S; Kim MN; Min WK
J Clin Lab Anal; 2016 Sep; 30(5):485-9. PubMed ID: 26499918
[TBL] [Abstract][Full Text] [Related]
16. Comparison of vancomycin area under the concentration-time curve (AUC) using two-point pharmacokinetics versus two open-access online single-concentration vancomycin calculators.
Ondrush NM; Ademovic R; Seabury RW; Darko W; Miller CD; Mogle BT
J Clin Pharm Ther; 2022 Dec; 47(12):2223-2229. PubMed ID: 36351763
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic/pharmacodynamic parameters of vancomycin for predicting clinical outcome of enterococcal bacteremia.
Nham E; Huh K; Sohn YM; Park HJ; Kim H; Woo SY; Ko JH; Cho SY; Kang CI; Chung DR; Huh HJ; Park HD; Lee NY; Peck KR
BMC Infect Dis; 2022 Aug; 22(1):686. PubMed ID: 35948963
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Bayesian-derived and first-order analytic equations for calculation of vancomycin area under the curve.
Olney KB; Wallace KL; Mynatt RP; Burgess DS; Grieves K; Willett A; Mani J; Flannery AH
Pharmacotherapy; 2022 Apr; 42(4):284-291. PubMed ID: 35134264
[TBL] [Abstract][Full Text] [Related]
20. Examining the Relationship Between Vancomycin Area Under the Concentration Time Curve and Serum Trough Levels in Adults With Presumed or Documented Staphylococcal Infections.
Clark L; Skrupky LP; Servais R; Brummitt CF; Dilworth TJ
Ther Drug Monit; 2019 Aug; 41(4):483-488. PubMed ID: 30817704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]